PZH significantly decreased the expression of ANRIL in subcutaneous xenograft (0.47 folds) and orthotopic xenograft tumor tissues (0.22 folds) (P < 0.01) (Fig. 4A). The gene discussed is CDKN2B-AS1; the disease is neoplasm.